| Product Code: ETC11387026 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The Japan antibiotics import market in 2024 continued to be dominated by a select few countries, with Indonesia, China, Metropolitan France, UK, and South Korea emerging as the top exporters. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a negative compound annual growth rate (CAGR) of -4.04% from 2020 to 2024. The growth rate for 2023-24 also saw a decline of -3.11%, reflecting a challenging environment for antibiotics import shipments into Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Antibiotics Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Antibiotics Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Antibiotics Market - Industry Life Cycle |
3.4 Japan Antibiotics Market - Porter's Five Forces |
3.5 Japan Antibiotics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Antibiotics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Japan Antibiotics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Antibiotics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Antibiotics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Japan |
4.2.2 Growing awareness about the importance of appropriate antibiotic use |
4.2.3 Technological advancements in antibiotic research and development |
4.3 Market Restraints |
4.3.1 Rising concerns about antibiotic resistance |
4.3.2 Stringent regulatory requirements for antibiotic approval and marketing |
4.3.3 Competition from alternative treatment options such as probiotics and natural remedies |
5 Japan Antibiotics Market Trends |
6 Japan Antibiotics Market, By Types |
6.1 Japan Antibiotics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Antibiotics Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Japan Antibiotics Market Revenues & Volume, By Beta-Lactams, 2021 - 2031F |
6.1.4 Japan Antibiotics Market Revenues & Volume, By Macrolides, 2021 - 2031F |
6.1.5 Japan Antibiotics Market Revenues & Volume, By Tetracyclines, 2021 - 2031F |
6.2 Japan Antibiotics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan Antibiotics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Japan Antibiotics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Japan Antibiotics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Antibiotics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Japan Antibiotics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Japan Antibiotics Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Japan Antibiotics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Antibiotics Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.4.3 Japan Antibiotics Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4.4 Japan Antibiotics Market Revenues & Volume, By Online, 2021 - 2031F |
7 Japan Antibiotics Market Import-Export Trade Statistics |
7.1 Japan Antibiotics Market Export to Major Countries |
7.2 Japan Antibiotics Market Imports from Major Countries |
8 Japan Antibiotics Market Key Performance Indicators |
8.1 Antibiotic consumption patterns in different age groups |
8.2 Rate of antibiotic prescriptions in outpatient settings |
8.3 Investment in research and development of new antibiotics |
8.4 Number of reported cases of antibiotic-resistant infections |
8.5 Public health campaigns promoting responsible antibiotic use |
9 Japan Antibiotics Market - Opportunity Assessment |
9.1 Japan Antibiotics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Antibiotics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Japan Antibiotics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Antibiotics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Antibiotics Market - Competitive Landscape |
10.1 Japan Antibiotics Market Revenue Share, By Companies, 2024 |
10.2 Japan Antibiotics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |